The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
CRISPR-Cas: biology, mechanisms and relevance
Abstract
Prokaryotes have evolved several defence mechanisms to protect themselves from viral predators. Clustered regularly interspaced short palindromic repeats (CRISPR) and their associated proteins (Cas) display a prokaryotic adaptive immune system that memorizes previous infections by integrating short sequences of invading genomes—termed spacers—into the CRISPR locus. The spacers interspaced with repeats are expressed as small guide CRISPR RNAs (crRNAs) that are employed by Cas proteins to target invaders sequence-specifically upon a reoccurring infection. The ability of the minimal CRISPR-Cas9 system to target DNA sequences using programmable RNAs has opened new avenues in genome editing in a broad range of cells and organisms with high potential in therapeutical applications. While numerous scientific studies have shed light on the biochemical processes behind CRISPR-Cas systems, several aspects of the immunity steps, however, still lack sufficient understanding. This review summarizes major discoveries in the CRISPR-Cas field, discusses the role of CRISPR-Cas in prokaryotic immunity and other physiological properties, and describes applications of the system as a DNA editing technology and antimicrobial agent. This article is part of the themed issue ‘The new bacteriology’.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
CRISPR and its associated protein (Cas-9) is a method of adaptive immunity in prokaryotes to defend themselves against viruses or bacteriophages.
“CRISPR and its associated protein (Cas-9) is a method of adaptive immunity in prokaryotes to defend themselves against viruses or bacteriophages.2”
From Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing (2021) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563
Self-citationRNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993
Kim, S., Kim, D., Cho, S. W., Kim, J., & Kim, J.-S. (2014) · Genome Research · doi:10.1101/gr.171322.113 · Cited by 1,856
TALENs: A widely applicable technology for targeted genome editing
Joung, J. K., & Sander, J. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3486 · Cited by 1,650
Schwank, G., Koo, B.-K., Sasselli, V., Dekkers, J. F., Heo, I., Demircan, T., Sasaki, N., Boymans, S., Cuppen, E., van der Ent, C. K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.11.002 · Cited by 1,424
Koike-Yusa, H., Li, Y., Tan, E.-P., Velasco-Herrera, M. D. C., & Yusa, K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2800 · Cited by 1,064
Thakore, P. I., D'Ippolito, A. M., Song, L., Safi, A., Shivakumar, N. K., Kabadi, A. M., Reddy, T. E., Crawford, G. E., & Gersbach, C. A. (2015) · Nature Methods · doi:10.1038/nmeth.3630 · Cited by 1,012
Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA
Ramakrishna, S., Kwaku Dad, A.-B., Beloor, J., Gopalappa, R., Lee, S.-K., & Kim, H. (2014) · Genome Research · doi:10.1101/gr.171264.113 · Cited by 655
Advances in therapeutic CRISPR/Cas9 genome editing
Savić, N., & Schwank, G. (2016) · Translational Research · doi:10.1016/j.trsl.2015.09.008 · Cited by 257
Flagged first, then by citations
Research works printed but not linked: 140
- 10.1126/science.1138140 · DOI · Paper page
- 10.1371/journal.pcbi.0010060 · DOI
- 10.1186/1745-6150-1-7 · DOI · Paper page
- 10.1007/s00239-004-0046-3 · DOI · Paper page
- 10.1038/nrmicro3569 · DOI · Paper page
- 10.1038/nrmicro2577 · DOI · Paper page
- 10.1016/j.molcel.2015.10.008 · DOI · Paper page
- 10.1016/j.virol.2012.10.003 · DOI
- 10.1016/j.biochi.2015.03.025 · DOI · Paper page
- 10.1038/nsmb.2820 · DOI · Paper page
- 10.1038/nature14237 · DOI · Paper page
- 10.7554/eLife.08716 · DOI
- 10.1093/nar/gku510 · DOI
- 10.1111/j.1365-2958.2010.07465.x · DOI · Paper page
- 10.1016/j.str.2009.03.019 · DOI · Paper page
- 10.1074/jbc.M803225200 · DOI
- 10.1093/nar/gks216 · DOI · Paper page
- 10.1093/nar/gku1407 · DOI
- 10.1093/nar/gkt1154 · DOI
- 10.1093/nar/gkv1261 · DOI
- 10.1038/nature14245 · DOI
- 10.1101/gad.257550.114 · DOI
- 10.1126/science.aad4234 · DOI · Paper page
- 10.1371/journal.pone.0035888 · DOI
- 10.1038/ncomms1937 · DOI · Paper page
- 10.1128/JB.01412-07 · DOI
- 10.1099/mic.0.023960-0 · DOI · Paper page
- 10.1038/nature17945 · DOI · Paper page
- 10.1016/j.cell.2015.09.038 · DOI · Paper page
- 10.1093/nar/gku527 · DOI
- 10.1073/pnas.1400071111 · DOI
- 10.1016/j.cell.2015.10.003 · DOI · Paper page
- 10.1101/gad.1742908 · DOI
- 10.1126/science.1192272 · DOI
- 10.1261/rna.033100.112 · DOI
- 10.1016/j.str.2012.06.016 · DOI
- 10.1093/nar/gks737 · DOI
- 10.1038/nsmb.2043 · DOI
- 10.1016/j.cell.2009.07.040 · DOI · Paper page
- 10.1073/pnas.1112832108 · DOI · Paper page
- 10.1093/femsre/fuv023 · DOI
- 10.1016/j.molcel.2013.05.001 · DOI
- 10.1146/annurev-genet-110410-132430 · DOI · Paper page
- 10.1038/nrg2749 · DOI · Paper page
- 10.1016/j.str.2010.11.014 · DOI
- 10.4161/rna.21410 · DOI
- 10.1016/j.molcel.2011.12.013 · DOI
- 10.1073/pnas.1104144108 · DOI · Paper page
- 10.1371/journal.pgen.1003742 · DOI
- 10.1038/nature08703 · DOI
- 10.1126/science.1159689 · DOI · Paper page
- 10.1016/j.molcel.2012.03.018 · DOI
- 10.1126/science.1165771 · DOI · Paper page
- 10.1111/mmi.12152 · DOI
- 10.1038/nature13637 · DOI
- 10.1016/j.cell.2015.04.027 · DOI · Paper page
- 10.1016/j.molcel.2014.10.005 · DOI
- 10.1016/j.molcel.2014.09.027 · DOI
- 10.1093/nar/gku161 · DOI
- 10.1038/nature09523 · DOI
- Nordström K, 1974, Effect of protein A on adsorption of bacteriophages to Staphylococcus aureus, J. Virol, 14, 198, 10.1128/JVI.14.2.198-202.1974 · DOI
- 10.1126/science.1067467 · DOI
- 10.1099/mic.0.28184-0 · DOI
- 10.1016/0966-842X(94)90601-7 · DOI
- 10.1016/j.virol.2006.03.001 · DOI
- 10.1007/s00018-004-4513-1 · DOI
- 10.1128/MMBR.57.2.434-450.1993 · DOI
- 10.1101/gad.6.3.497 · DOI
- 10.1074/jbc.M002546200 · DOI
- 10.1073/pnas.93.12.6059 · DOI
- 10.1073/pnas.0808832106 · DOI
- 10.15252/embj.201489455 · DOI
- 10.1038/nature12971 · DOI
- 10.1073/pnas.1524385113 · DOI
- 10.1016/j.molcel.2013.08.014 · DOI
- 10.1038/nature17436 · DOI
- 10.1038/nature11723 · DOI
- 10.1128/mBio.00896-14 · DOI
- 10.1038/nature15254 · DOI
- 10.1038/nature11927 · DOI
- 10.1128/MMBR.05026-11 · DOI
- 10.1038/nature14302 · DOI
- 10.1093/nar/gkv1213 · DOI
- 10.1038/nature12048 · DOI
- 10.1007/s10096-012-1733-4 · DOI
- 10.1128/mBio.00074-13 · DOI
- 10.1093/nar/gkl1096 · DOI
- 10.1101/gad.1.8.840 · DOI
- 10.1128/jb.175.22.7450-7462.1993 · DOI
- 10.1128/JB.00187-07 · DOI
- 10.1128/JB.02035-14 · DOI
- 10.1371/journal.pgen.1003454 · DOI
- 10.1128/JB.188.7.2364-2374.2006 · DOI
- 10.1016/j.tig.2010.05.008 · DOI
- 10.1111/j.1365-2958.1993.tb00976.x · DOI · Paper page
- Kamerbeek J, 1997, Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology, J. Clin. Microbiol, 35, 907, 10.1128/JCM.35.4.907-914.1997 · DOI
- 10.1099/mic.0.27437-0 · DOI · Paper page
- 10.1371/journal.pone.0002652 · DOI
- 10.1128/AEM.00468-11 · DOI
- 10.1128/AEM.02625-10 · DOI
- 10.1007/s10096-008-0674-4 · DOI
- 10.1002/biot.200700035 · DOI
- 10.1038/nbt.3043 · DOI · Paper page
- 10.1038/nbt.3011 · DOI · Paper page
- 10.1128/mBio.00928-13 · DOI
- 10.1073/pnas.1500107112 · DOI · Paper page
- 10.1038/nrg2842 · DOI · Paper page
- 10.1016/j.mrrev.2003.07.001 · DOI
- van den Bosch M, 2002, DNA double-strand break repair by homologous recombination, Biol. Chem, 383, 873
- 10.1016/S0960-9822(01)00279-2 · DOI · Paper page
- 10.1038/nprot.2013.132 · DOI
- 10.1038/nmeth.2598 · DOI · Paper page
- 10.1093/nar/gkt520 · DOI · Paper page
- 10.1038/nbt.3199 · DOI
- 10.1016/j.tibtech.2016.02.004 · DOI
- 10.1093/nar/gku1257 · DOI
- 10.1093/nar/gku971 · DOI
- 10.1038/nbt.2884 · DOI · Paper page
- 10.1073/pnas.1405186111 · DOI · Paper page
- 10.1016/j.celrep.2016.03.042 · DOI
- 10.1146/annurev.immunol.17.1.657 · DOI · Paper page
- 10.1038/382722a0 · DOI
- 10.1073/pnas.1407473111 · DOI · Paper page
- 10.1016/j.cell.2015.02.038 · DOI · Paper page
- 10.1126/science.1246981 · DOI · Paper page
- 10.1128/jb.169.12.5429-5433.1987 · DOI · Paper page
- 10.1099/mic.0.28048-0 · DOI · Paper page
- 10.1093/nar/gkr606 · DOI
- 10.1111/j.1365-2958.2010.07073.x · DOI · Paper page
- 10.1016/j.chom.2012.06.003 · DOI
- 10.1128/mBio.00227-10 · DOI
- 10.1016/j.mib.2013.12.001 · DOI
- 10.1038/ismej.2015.20 · DOI
- 10.1016/j.cub.2015.01.065 · DOI
- 10.1128/mBio.00456-12 · DOI
- 10.1098/rspb.2015.1270 · DOI
- 10.1016/j.cell.2014.05.010 · DOI · Paper page
- 10.1016/j.cell.2013.08.021 · DOI · Paper page
- 10.1101/gr.162339.113 · DOI · Paper page
- 10.1089/hum.2015.074 · DOI
Cited by
Sorted by citations
Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing
Mengstie, M. A., & Wondimu, B. Z. (2021) · Biologics: Targets and Therapy · doi:10.2147/btt.s326422 · Cited by 478
The application of the CRISPR-Cas system in antibiotic resistance
Tao, S., Chen, H., Li, N., & Liang, W. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s370869 · Cited by 147
Recent advancements in reducing the off-target effect of CRISPR/Cas9 genome editing
Asmamaw Mengstie, M., Teshome Azezew, M., Asmamaw Dejenie, T., Teshome, A. A., Tadele Admasu, F., Behaile Teklemariam, A., Tilahun Mulu, A., Mekonnen Agidew, M., Adugna, D. G., Geremew, H., et al. (2024) · Biologics: Targets and Therapy · doi:10.2147/btt.s429411 · Cited by 91
Emerging applications of gene editing technologies for the development of climate-resilient crops
Chavhan, R. L., Jaybhaye, S. G., Hinge, V. R., Deshmukh, A. S., Shaikh, U. S., Jadhav, P. K., Kadam, U. S., & Hong, J. C. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1524767 · Cited by 55
“These domains cut the dsDNA three base pairs upstream of the PAM sequence (5 ′ -NGG or 5 ′ -NAG) (Jiang and Doudna, 2017; Hille and Charpentier, 2016; Manghwar et al., 2019).”
Interaction of phages, bacteria, and the human immune system: Evolutionary changes in phage therapy
Jariah, R. O. A., & Hakim, M. S. (2019) · Reviews in Medical Virology · doi:10.1002/rmv.2055 · Cited by 40
Learning to quantify uncertainty in off-target activity for CRISPR guide RNAs
Özden, F., & Minary, P. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae759 · Cited by 21
Metadata
- Authors
- Hille, F., & Charpentier, E.
- Affiliations
- Department of Regulation in Infection Biology, Max Planck Institute for Infection Biology, Berlin 10117, Germany
- Venue
- Philosophical Transactions of the Royal Society B: Biological Sciences
- Publisher
- The Royal Society
- Published
- 2016-11-05
- Volume
- 371
- Issue
- 1707
- Pages
- 20150496
- ISSN
- 0962-8436
- 1471-2970
- PMC
- PMC5052741
- Cited by
- 442
- References
- 17
- Language
- en
- Funders
- Vetenskapsrådet
- Max-Planck-Gesellschaft
- Bundesministerium für Bildung und Forschung
- Göran Gustafssons Stiftelse för Naturvetenskaplig och Medicinsk Forskning
- Umea University
- Deutsche Forschungsgemeinschaft
- Alexander von Humboldt-Stiftung
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review